Skip to main content

Oregon State Flag An official website of the State of Oregon »

Oregon.gov Homepage

Recently adopted rules

New Rules

New rules are posted on this page for six months after they are final.

Click on a rule title below for details.

Finance and securities regulation

REPEAL TEMP RULES: OAR 441-840-0010(T), 441-840-0020(T), 441-840-0030(T), 441-840-0040(T), 441-840-0050(T), 441-840-0060(T), 441-840-0070(T), 441-840-0080(T), 441-840-0090(T)

ADOPTED RULES: OAR 441-840-0010, 441-840-0020, 441-840-0030, 441-840-0040, 441-840-0050, 441-840-0060, 441-840-0070, 441-840-0080, 441-840-0090

RULE SUMMARY: HB 2052 (2023) requires a data broker to register with the Department of Consumer and Business Services (DCBS) prior to collecting and selling or licensing brokered personal data to another person. The purpose of this rulemaking is to effectuate a program to prevent data brokers from collecting and selling or licensing personal data of Oregonians without registration. The registration program will provide Oregonians with important information about what data brokers might have their data, and how they can opt-out of the sale or request deletion of their data.

FILED: 5/21/2024

EFFECTIVE: 05/28/2024

DOCUMENTS: PERMANENT ADMINISTRATIVE ORDER​​

​

​​Rules affected: OAR 441-135-0020

Rules summary: OAR 441-135-0020(1)(e)(E) and 441-135-0020(4)(c) are deleted from the current version of the rule to permit the use of professional designations or certifications unless they falsely indicate or imply that the person has special certification or training, in connection with the offer, sale or purchase of securities, or the provision of advice as to the value of or the advisability of investing in, purchasing, or selling securities, directly or indirectly, or through a publication or writing, or by issuing or disseminating analyses or reports relating to securities.

Filed: 02/26/2024

Effective: 03/01/2024

Documents: PERMANENT ADMINISTRATIVE ORDER

Prescription Drug Afforability Board (PDAB)

​​Newly adopted rules for the Prescription Drug Afforability Board will appear here when they are filed with the Oregon Secretary of State.


Insurance regulation

​​​Amend: OAR 836-051-0905, 836-080-0170, 836-080-0172, 836-080-0178, 836-080-0183, 836-080-0185, 836-080-0190

​​​Repeal: OAR 836-080-0175, 836-080-0180, 836-080-0188

Rule summary: ​Senate Bill 536 (SB 536), codified at ORS 743.262, was adopted during the 2023 Legislative Session and establishes disclosure and care obligations for sales of annuities to prospective purchasers. SB 536 closely aligns with the National Association of Insurance Commissioners (NAIC) updated Model Regulation #275 - Suitability in Annuity Transactions Model Regulation.

In 2020, the NAIC revised Model Regulation #275 language by incorporating a consumer disclosure and care obligations for annuity sales, a higher level of consumer care compared to the previous product suitability standard. Under these standards, insurance producers, insurers, and securities-brokers must meet specific care obligation in recommending products to consumers by taking into account the circumstances known at the time an annuity product recommendation is made.

Filed: 8/12/2024

Effective: 08/12/2024

Documents:
​ Permanent Administrative Rule​

​

​​Adopt: OAR 836-200-0553

Rule Summary: Adopted annual fees paid by drug manufacturers.

Amend: OAR 836-200-0555

Rule Summary: Amended assessments against prescription drug manufacturers for 2023 and prior.

Filed: 7/31/2024

Effective: 8/01/2024

Documents:
​ Permanent Administrative Rule​

​​​

​​AMEND: OAR 836-053-0013

RULE SUMMARY: Update Standard Bronze and Silver Plans​

FILED: 06/24/2024

EFFECTIVE DATE: 07/01/2024

DOCUMENTS: Permanent Administrative Order​​
Exhibit 1: 2025 Bronze plan cost-sharing matrix​
Exhibit 2: 2025 Silver plan cost-sharing matrix

​​AMEND: OAR 836-053-0473

RULE SUMMARY: This rule describes the materials that must be filed by an insurer as part of a rate filing for small group and individual health benefit plans. The amendment removes the language related to annual reporting by insurers for the Drug Price Transparency program.

​​ADOPT: OAR 836-053-1630

RULE SUMMARY: This rule restates the language removed from OAR 836-053-0473 with slight modification to reflect the expanded reporting requirements. This rule describes the information that must be submitted by insurers annually to the Drug Price Transparency program.

FILED: 4/29/24

EFFECTIVE DATE: 05/01/2024

DOCUMENTS: Permanent Administrative Order​​

​​

Agency Mailing / Interested Party List:

If you are interested in receiving notices of all Division of Financial Regulation administrative rule changes, please sign-up via the link below and select "Proposed Rules" and "Recently Adopted Rules"

Email notification

This electronic notification service is used to send notifications of all administrative rule changes per ORS 183.335(8). Please note each subscriber must keep their subscription choices and email address up to date to ensure they receive the appropriate notices.

If you have questions or if you need to request hard copy notices, you may contact Karen Winkel via email at [email protected].

​Key links

Oregon Revised Statutes
Oregon Administrative Rules​​
Oregon State Legislature​​ ​